Loading investment round...
Cubit Diagnostics — Developing advanced molecular and immunoassay diagnostic solutions for point-of-care testing.
No investors disclosed.
Cubit Diagnostics
SAFE · May 7, 2026
—
Grant · Sep 30, 2025
$307K